Research Hub

Milestones
Global searchLocal Demo

Milestones

Hide

Milestone schedule and completion status by program and quarter. Business and scientific purpose: this view supports faster, evidence-based drug discovery decisions across research, operations, and governance teams. Milestones is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.

idprogramIdmilestonequarterstatus
MS-001PRG-002Hit-to-lead2026-Q1at-risk
MS-002PRG-006IND-enabling2026-Q2on-track
MS-003PRG-009IND-enabling2026-Q3on-track
MS-004PRG-010IND-enabling2026-Q4completed
MS-005PRG-020Hit-to-lead2026-Q1on-track
MS-006PRG-011IND-enabling2026-Q2at-risk
MS-007PRG-016Hit-to-lead2026-Q3completed
MS-008PRG-006IND-enabling2026-Q4on-track
MS-009PRG-019Hit-to-lead2026-Q1on-track
MS-010PRG-004Lead optimization2026-Q2completed
MS-011PRG-020Lead optimization2026-Q3at-risk
MS-012PRG-019Hit-to-lead2026-Q4on-track
MS-013PRG-012Lead optimization2026-Q1completed
MS-014PRG-001Lead optimization2026-Q2on-track
MS-015PRG-019Lead optimization2026-Q3on-track
MS-016PRG-020Hit-to-lead2026-Q4at-risk
MS-017PRG-016Lead optimization2026-Q1on-track
MS-018PRG-006Lead optimization2026-Q2on-track
MS-019PRG-011Hit-to-lead2026-Q3completed
MS-020PRG-007Hit-to-lead2026-Q4on-track
MS-021PRG-012IND-enabling2026-Q1at-risk
MS-022PRG-015Lead optimization2026-Q2completed
MS-023PRG-017IND-enabling2026-Q3on-track
MS-024PRG-007Lead optimization2026-Q4on-track
MS-025PRG-007IND-enabling2026-Q1completed
MS-026PRG-008IND-enabling2026-Q2at-risk
MS-027PRG-011Lead optimization2026-Q3on-track
MS-028PRG-022Lead optimization2026-Q4completed
MS-029PRG-016IND-enabling2026-Q1on-track
MS-030PRG-007IND-enabling2026-Q2on-track
MS-031PRG-010Hit-to-lead2026-Q3at-risk
MS-032PRG-023Lead optimization2026-Q4on-track
MS-033PRG-011Lead optimization2026-Q1on-track
MS-034PRG-013Hit-to-lead2026-Q2completed
MS-035PRG-009Lead optimization2026-Q3on-track
MS-036PRG-018Lead optimization2026-Q4at-risk
MS-037PRG-017IND-enabling2026-Q1completed
MS-038PRG-001Hit-to-lead2026-Q2on-track
MS-039PRG-011Lead optimization2026-Q3on-track
MS-040PRG-017IND-enabling2026-Q4completed
MS-041PRG-020Lead optimization2026-Q1at-risk
MS-042PRG-024Lead optimization2026-Q2on-track
MS-043PRG-010Hit-to-lead2026-Q3completed
MS-044PRG-022Lead optimization2026-Q4on-track
MS-045PRG-009Hit-to-lead2026-Q1on-track
MS-046PRG-008Hit-to-lead2026-Q2at-risk
MS-047PRG-003IND-enabling2026-Q3on-track
MS-048PRG-024IND-enabling2026-Q4on-track
MS-049PRG-019Hit-to-lead2026-Q1completed
MS-050PRG-013Lead optimization2026-Q2on-track
MS-051PRG-015IND-enabling2026-Q3at-risk
MS-052PRG-018Lead optimization2026-Q4completed
MS-053PRG-015IND-enabling2026-Q1on-track
MS-054PRG-008Hit-to-lead2026-Q2on-track
MS-055PRG-006Lead optimization2026-Q3completed
MS-056PRG-009Lead optimization2026-Q4at-risk
MS-057PRG-007Hit-to-lead2026-Q1on-track
MS-058PRG-007Lead optimization2026-Q2completed
MS-059PRG-003Hit-to-lead2026-Q3on-track
MS-060PRG-020IND-enabling2026-Q4on-track
MS-061PRG-012Lead optimization2026-Q1at-risk
MS-062PRG-006Lead optimization2026-Q2on-track
MS-063PRG-018Lead optimization2026-Q3on-track
MS-064PRG-010Hit-to-lead2026-Q4completed
MS-065PRG-006IND-enabling2026-Q1on-track
MS-066PRG-017IND-enabling2026-Q2at-risk
MS-067PRG-004Lead optimization2026-Q3completed
MS-068PRG-019Lead optimization2026-Q4on-track
MS-069PRG-021Hit-to-lead2026-Q1on-track
MS-070PRG-006Hit-to-lead2026-Q2completed
MS-071PRG-021Hit-to-lead2026-Q3at-risk
MS-072PRG-023IND-enabling2026-Q4on-track
MS-073PRG-017Hit-to-lead2026-Q1completed
MS-074PRG-001Hit-to-lead2026-Q2on-track
MS-075PRG-024IND-enabling2026-Q3on-track
MS-076PRG-019Lead optimization2026-Q4at-risk
MS-077PRG-007Hit-to-lead2026-Q1on-track
MS-078PRG-013IND-enabling2026-Q2on-track
MS-079PRG-021Hit-to-lead2026-Q3completed
MS-080PRG-007IND-enabling2026-Q4on-track